At a glance
- Originator Pfizer
- Class Antifungals
- Mechanism of Action Myristoyl transferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Aspergillosis; Candidiasis
Most Recent Events
- 15 Dec 2003 No development reported - Preclinical for Candidiasis in United Kingdom (unspecified route)
- 15 Dec 2003 No development reported - Preclinical for Aspergillosis in United Kingdom (unspecified route)
- 27 Apr 2001 New profile